There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower drug prices. Patients want the best of the best options for devices,…
The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Judging by the most shorted stocks traded on the New York Stock Exchange between the December 31 and January 15 settlement dates, those sellers were looking for direction, as short interest moves…
Bristol-Myers Squibb reported better-than-expected quarterly results before the markets opened on Thursday.
Chris Lange The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Thursday was a down day for the broad U.S. markets. After a fairly decent Wednesday, markets as a whole took a sharp turn downward. Perhaps a driving force from this was Apple…
Apple, Bristol-Myers, Delta Air Lines, and United Continental all posted new 52-week lows on Thursday.
Bristol-Myers has announced a definitive agreement to acquire rival Celgene in a cash and stock deal worth $74 billion. Celgene shareholders are scheduled to receive a 54% premium to Wednesday night's closing…
The December 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The November 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
24/7 Wall St. takes a look at what is coming up in the FDA calendar regarding biotech and pharmaceutical companies expecting updates to their drug pipeline or other major events for the…
The top analyst upgrades, downgrades and initiations seen on Thursday included Alphabet, American Water, Apple, Facebook, Macy's, Southern Copper, Twitter and YY.
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Bristol-Myers Squibb shares dipped on Tuesday after the company reported results from its late-stage lung cancer study.
Chris Lange The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
